← Evidence map

ArticleMolecular cancer therapeutics2022

AZD4625 is a Potent and Selective Inhibitor of KRASG12C.

Atanu Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35930755